ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice - Wikidata - wikimedia - TriplyDB

ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice

ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice

http://www.wikidata.org/entity/Q34745279

about

Pituitary tumors.Over-expression of LRIG1 suppresses biological function of pituitary adenoma via attenuation of PI3K/AKT and Ras/Raf/ERK pathways in vivo and in vitro.Role of tyrosine kinase inhibitors in the treatment of pituitary tumours: from bench to bedside.Recent Progress in the Medical Therapy of Pituitary Tumors Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas.EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis.Pituitary Gene Signalling Pathway Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease

P2860

Q35154035-BA224208-2AF1-4F5F-B766-4B3A1D00DB26 Q38755339-D4B9C430-A122-42F5-9E8D-0B4403B9A9E4 Q38777251-A8B3A129-9EB9-456B-880D-29FE2A3D7591 Q39420116-F2385FF9-2A22-4E4A-953C-5A5341F57B62 Q47168700-DDB3D778-4A32-4227-97D2-7B1FFBD9F2AC Q52738992-308344C2-E1FB-4CE2-85BF-B1D827D2A9AA Q58616038-48B70210-562F-45BD-8B0B-F18089A0BE0A Q58789954-5F44D3D4-4B36-4F0D-9BAA-BBC705504BE6

P2860

ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice

http://www.wikidata.org/entity/Q34745279

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

ErbB receptor-driven prolactin ...... ment in female transgenic mice

@ast

ErbB receptor-driven prolactin ...... ment in female transgenic mice

@en

ErbB receptor-driven prolactin ...... ment in female transgenic mice

@nl

type

label

ErbB receptor-driven prolactin ...... ment in female transgenic mice

@ast

ErbB receptor-driven prolactin ...... ment in female transgenic mice

@en

ErbB receptor-driven prolactin ...... ment in female transgenic mice

@nl

prefLabel

ErbB receptor-driven prolactin ...... ment in female transgenic mice

@ast

ErbB receptor-driven prolactin ...... ment in female transgenic mice

@en

ErbB receptor-driven prolactin ...... ment in female transgenic mice

@nl

P1433

Q34745279-AE3D8C1D-C0A5-4415-9BE2-816A2B005872

P1476

Q34745279-63F6F215-AE91-4A77-8868-10BA3AA306DC

P2093

Q34745279-23822390-0B43-4793-AC0D-F71A03FF9347

Q34745279-71DEB6DF-BD00-4298-814A-9B7ED4207578

Q34745279-8D5A10FD-12E0-4B17-8591-335F4821A6B2

Q34745279-A8BCE682-5BE4-42D8-BE58-F0AC0F2123E3

Q34745279-CDA6990D-87B4-48F8-91CE-1C079356FAC7

Q34745279-E440ACE5-716D-4811-9E5A-12B5ACDABD4F

Q34745279-E6874B82-D568-49B8-A14E-F7DBA6F50A4D

P2860

Q34745279-03939BB2-D238-4E0D-924A-F5A74240D37F

Q34745279-0654C3FB-7963-4D16-BD9C-CDFD3F02E0C9

Q34745279-06FD7965-1E8E-4DB9-836E-8978E86A7766

Q34745279-0B18C7A0-BC20-4F8E-9B66-FDA020C72152

Q34745279-1DA115C3-B8B7-4F7F-B300-912059DC25C2

Q34745279-1E778DD0-23E0-41C9-A20F-C24398015009

Q34745279-24DB75C5-F92A-444E-9885-E44E74B32E9B

Q34745279-2B50F0A5-3C37-4069-80C4-ABD09043758B

Q34745279-33C3D983-A67A-41C8-9174-CA1A7E19844B

Q34745279-36D9549F-2B47-420A-9CDC-AE4D7BF727DA

P304

Q34745279-391CD14B-27E9-464A-A637-D86123A13560

P31

Q34745279-5F19E86A-CC22-49D0-8A77-0F7D80A18172

P356

Q34745279-CC2F6FB0-9A95-4ECE-8F69-23C7C641DD08

P407

Q34745279-69CBA915-78CB-4A26-A2E5-D7053832B489

P433

Q34745279-2E1CC8A5-1DBD-4506-B9A9-74E3E481346A

P478

Q34745279-4BFD7246-3889-4E56-9A04-6D52B2E97271

P50

Q34745279-43B7865E-E46E-4E77-9393-693588FA3629

P577

Q34745279-FD7F4141-36F2-4D6E-B568-C1409850DC89

P5875

Q34745279-01E3D741-9C2D-4A3D-9E51-B16FAF09A6B0

P698

Q34745279-C1B15B7E-631A-43D4-BD26-6F2998670658

P932

Q34745279-2539B9AB-2581-4ACE-94F0-8BC385348365

P356

P1433

P1476

ErbB receptor-driven prolactin ...... ment in female transgenic mice

@en

P2093

Hidenori Fukuoka

http://www.w3.org/2001/XMLSchema#string

Masahide Tone

http://www.w3.org/2001/XMLSchema#string

Maya Kano

http://www.w3.org/2001/XMLSchema#string

Shlomo Melmed

http://www.w3.org/2001/XMLSchema#string

Takako Araki

http://www.w3.org/2001/XMLSchema#string

Xiaohai Liu

http://www.w3.org/2001/XMLSchema#string

Yukiko Tone

http://www.w3.org/2001/XMLSchema#string

P2860

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

ErbB receptors: from oncogenes to targeted cancer therapies

Designing a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing.

Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors

Pituitary surgery: transsphenoidal approach.

Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors.

Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.

Hyperprolactinemia and prolactinomas.

HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy.

P304

71-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2014-1627

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

156

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267872441

http://www.w3.org/2001/XMLSchema#string

P698

25375038

http://www.w3.org/2001/XMLSchema#string

P932

4272404

http://www.w3.org/2001/XMLSchema#string